1. Up Front

   Up Front 16 March 2023 Pages: 783 - 785

   

2. Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes

   • Nita G. Forouhi

   Review Open access 14 February 2023 Pages: 786 - 799

   

3. Causal factors underlying diabetes risk informed by Mendelian randomisation analysis: evidence, opportunities and challenges

   • Shuai Yuan
   • Jordi Merino
   • Susanna C. Larsson

   Review Open access 14 February 2023 Pages: 800 - 812

   

4. Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial

   • Søren Gullaksen
   • Liv Vernstrøm
   • Esben Laugesen

   Article 06 February 2023 Pages: 813 - 825

   

5. Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study

   • Ida H. Thorius
   • Lise Lotte N. Husemoen
   • Elisabeth R. Mathiesen

   Article 14 January 2023 Pages: 826 - 836

   

6. Risk of kidney disease following a pregnancy complicated by diabetes: a longitudinal, population-based data-linkage study among Aboriginal women in the Northern Territory, Australia

   • Matthew J. L. Hare
   • Louise J. Maple-Brown
   • Federica Barzi

   Article Open access 18 January 2023 Pages: 837 - 846

   

7. The utility of a type 2 diabetes polygenic score in addition to clinical variables for prediction of type 2 diabetes incidence in birth, youth and adult cohorts in an Indigenous study population

   • Lauren E. Wedekind
   • Anubha Mahajan
   • Robert L. Hanson

   Article Open access 02 March 2023 Pages: 847 - 860

   

8. Sex differences in body composition in people with prediabetes and type 2 diabetes as compared with people with normal glucose metabolism: the Maastricht Study

   • Rianneke de Ritter
   • Simone J. S. Sep
   • Coen D. A. Stehouwer

   Article Open access 20 February 2023 Pages: 861 - 872

   

9. Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response

   • Dominik Lutter
   • Stephan Sachs
   • Susanna M. Hofmann

   Article Open access 15 February 2023 Pages: 873 - 883

   

10. Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells

    • René van Tienhoven
    • Maria J. L. Kracht
    • Bart O. Roep

    Article Open access 08 March 2023 Pages: 884 - 896

    

11. Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops

    • Ilaria Marzinotto
    • David L. Pittman
    • participating laboratories

    Article Open access 10 February 2023 Pages: 897 - 912

    

12. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation

    • Shao-Wen Weng
    • Jian-Ching Wu
    • Pei-Wen Wang

    Article 24 January 2023 Pages: 913 - 930

    

13. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice

    • Da Som Lee
    • Tae Hyeon An
    • Kyoung-Jin Oh

    Article Open access 10 February 2023 Pages: 931 - 954

    

14. Determination of autoantibodies in type 2 diabetes: one simple way to improve classification

    • Johnny Ludvigsson

    Letter 11 January 2023 Pages: 955 - 957

15. Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Lean et al to Ludvigsson J [letter]

    • Michael E. J. Lean
    • Roy Taylor
    • Naveed Sattar

    Letter 24 January 2023 Pages: 958 - 959

16. Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Laferrère to Ludvigsson J [letter]

    • Blandine Laferrère

    Letter 31 January 2023 Pages: 960 - 961